Holbert S Elliott, Patel Darren, Rizk Tony, Dimitri Nahu G, Jones Micah
Surgery, Edward Via College of Osteopathic Medicine, Blacksburg, USA.
Orthopedics, Edward Via College of Osteopathic Medicine, Blacksburg, USA.
Cureus. 2020 Aug 19;12(8):e9881. doi: 10.7759/cureus.9881.
Topical hemostatic agents are commonly used in a wide variety of surgical procedures to assist in hemostasis. However, the use of these agents is not without risk as many contain biologically active agents derived from human and animal products that have the potential to cause adverse reactions. This case report covers a 44-year-old man with a history of alpha-gal syndrome who was scheduled for an open reduction and internal fixation of a left distal radius fracture. Alpha-gal syndrome is characterized by an IgE-mediated type 1 hypersensitivity reaction to a mammalian oligosaccharide epitope. Patients with this condition have a history of a past tick bite and subsequent development of an allergic reaction to mammalian protein products, most notably red meat. The patient had concerns about products used during surgery and potential reactions based on his allergy. The intent of this case report is to promote physician awareness of the widespread use of mammalian products in surgical hemostatic agents and potential immunogenic reactions. By increasing awareness of the alpha-gal syndrome, the goal is that medical device companies will actively disclose product components that could potentiate these adverse reactions and continue to develop alternative agents.
局部止血剂常用于各种外科手术中以协助止血。然而,这些药剂的使用并非没有风险,因为许多药剂含有源自人类和动物产品的生物活性剂,有可能引起不良反应。本病例报告涵盖一名44岁患有α-半乳糖综合征的男性,他计划接受左桡骨远端骨折的切开复位内固定术。α-半乳糖综合征的特征是对哺乳动物寡糖表位的IgE介导的1型超敏反应。患有这种疾病的患者有蜱虫叮咬史,随后对哺乳动物蛋白产品产生过敏反应,最明显的是红肉。患者担心手术中使用的产品以及基于其过敏可能产生的反应。本病例报告的目的是提高医生对哺乳动物产品在外科止血剂中的广泛使用以及潜在免疫原性反应的认识。通过提高对α-半乳糖综合征的认识,目标是医疗器械公司将积极披露可能加剧这些不良反应的产品成分,并继续开发替代药剂。